|
1
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brenner H, Kloor M and Pox CP: Colorectal
cancer. Lancet. 383:1490–1502. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yiu AJ and Yiu CY: Biomarkers in
colorectal cancer. Anticancer Res. 36:1093–1102. 2016.PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lin S and Gregory RI: MicroRNA biogenesis
pathways in cancer. Nat Rev Cancer. 15:321–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
An NN, Shawn J, Peng JP, Wu MD and Huang
LG: Up-regulation of miR-190b promoted growth, invasion, migration
and inhibited apoptosis of Wilms' tumor cells by repressing the
PTEN expression. Eur Rev Med Pharmacol Sci. 22:961–969.
2018.PubMed/NCBI
|
|
7
|
Cizeron-Clairac G, Lallemand F, Vacher S,
Lidereau R, Bieche I and Callens C: MiR-190b, the highest
up-regulated miRNA in ERα-positive compared to ERα-negative breast
tumors, a new biomarker in breast cancers? BMC Cancer. 15:4992015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hung TM, Ho CM, Liu YC, Lee JL, Liao YR,
Wu YM, Ho MC, Chen CH, Lai HS and Lee PH: Up-regulation of
microRNA-190b plays a role for decreased IGF-1 that induces insulin
resistance in human hepatocellular carcinoma. PLoS One.
9:e894462014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kang M, Xia P, Hou T, Qi Z, Liao S and
Yang X: MicroRNA-190b inhibits tumor cell proliferation and induces
apoptosis by regulating Bcl-2 in U2OS osteosarcoma cells.
Pharmazie. 72:279–282. 2017.PubMed/NCBI
|
|
10
|
Wang C and Qiao C: MicroRNA-190b confers
radio-sensitivity through negative regulation of Bcl-2 in gastric
cancer cells. Biotechnol Lett. 39:485–490. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee JH, Hwang I, Kang YN, Choi IJ and Kim
DK: Genetic characteristics of mitochondrial DNA was associated
with colorectal carcinogenesis and its prognosis. PLoS One.
10:e01186122015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li T, Jian X, He H, Lai Q, Li X, Deng D,
Liu T, Zhu J, Jiao H, Ye Y, et al: MiR-452 promotes an aggressive
colorectal cancer phenotype by regulating a Wnt/β-catenin positive
feedback loop. J Exp Clin Cancer Res. 37:2382018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu H, Li D, Fang H and Ning J:
Species-specific function of microRNA-7702 in human colorectal
cancer cells via targeting TADA1. Am J Transl Res. 10:2579–2589.
2018.PubMed/NCBI
|
|
15
|
Chen MT, Sun HF, Li LD, Zhao Y, Yang LP,
Gao SP and Jin W: Downregulation of FOXP2 promotes breast cancer
migration and invasion through TGFβ/SMAD signaling pathway. Oncol
Lett. 15:8582–8588. 2018.PubMed/NCBI
|
|
16
|
Yu Z, Lin X, Tian M and Chang W:
microRNA-196b promotes cell migration and invasion by targeting
FOXP2 in hepatocellular carcinoma. Oncol Rep. 39:731–738.
2018.PubMed/NCBI
|
|
17
|
Diao H, Ye Z and Qin R: miR-23a acts as an
oncogene in pancreatic carcinoma by targeting FOXP2. J Investig
Med. 66:676–683. 2018. View Article : Google Scholar : PubMed/NCBI
|
